The pharmacokinetics of fosfomycin, administered intravenously and orally at two different doses (20 and 40 mg/kg of body weight), was studied in seven volunteers. The elimination profile of this antibiotic, when administered intravenously, followed a two-compartment kinetic model, independent of dosage, giving an elimination half-life of 2.23 ± 0.62 h and an average total volume of distribution at steady state of 0.34 liter/kg. Peak serum levels after rapid intravenous administration of 20 and 40 mg/kg were 132.1 ± 31.8 and 259.3 ± 32.5 ,ug/ml, respectively.
Fosfomycin, a broad-spectrum bactericidal agent which inhibits the cell wall synthesis of both gram-positive and gram-negative bacteria (4, 8, 17) , was discovered in Streptomyces fradiae fernentation broths (15) .
Although pharmacokinetic properties of fosfomycin have been studied in humans (1, 12) after intravenous and oral administration of 250-or 500-mg doses, the pharmacokinetics of larger doses employed therapeutically have not been investigated.
The work reported here was undertaken specifically (i) to describe the pharnacokinetics of single relatively larger intravenous and oral doses of fosfomycin and (ii) to utilize these pharmacokinetic data to determine patient dosage schedules and methods of administration.
MATERIALS AND METHODS
Human volunteers. Seven adult male volunteers participated in this study after informed written consent had been obtained. Their ages ranged from 25 to 56 years (mean ± standard deviation, 36.3 ± 12.3 years), and their body weight ranged from 45 to 70 kg (57.9 ± 7.0 kg). Prestudy physical examination and pre-and postdrug laboratory findings were normal. No volunteer had a history of allergy to antibiotics or other drugs. None had taken any drug during the month before the investigational period.
Dosage. Fosfomycin disodium (lot CS-906; Meiji Seika Research Laboratories, Tokyo, Japan) dissolved in 0.9% saline was administered intravenously at a concentration of 100 (1) where A, B, a (h-'), and ,B (h-') denote the hybrid constants. The apparent steady state volume of distribution, Vdss (liters), the distribution rate constants k12, k21 and k1o (h-'), the elimination rate constant from the central compartment, and the area under the curve (AUCo') were calculated by the usual procedure with equation 1 (3, 6) . The area-derived volume of distribution was also calculated by the usual procedure (6) .
The C,, after single oral administration, were fitted to a one-compartment open model by using the following equation (14) .
where ka is the apparent first-order absorption rate constant (h-1), ke. is the apparent first-order elimination rate constant (h-1), Vd is the apparent volume of distribution (liters), F is the apparent fraction of the dose available, and to is the lag time preceding initiation of absorption (hours). Both fosfomycin disodium salt and fosfomycin calcium salt are present in the blood in ionized form, and with fosfomycin there is no first-pass effect (9) . Therefore, F was determined by equation 3 (16) , and subsequent calculation of the other pharmacokinetic parameters was performed.
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The predicted time of the peak serum level after oral administration (tma.) was 
RESULTS
The mean serum levels of fosfomycin after intravenous administration of 20 and 40 mg/kg are shown in Fig. 1 Fig. 2 . The observed maximum concentration (Cmax) ranged from 4.4 to 8.6 ,ug/ml and from 6.9 to 13.4 jig/ml after administration of the respective doses. The mean t,,. calculated by using equation 4 were 2.3 ± 0.3 and 2.7 ± 0.2 h, respectively. There was an increase in serum concentration with the high doses, but this was not proportional to the dosage increment.
The pharmacokinetic data analyzed by using equation 2 are summarized in Table 2 . At doses of 20 and 40 mg/kg, the mean value of kel was 0.24 and 0.14 h-' and that of Vd was 0.52 and 1.04 liters/kg, respectively. Although these data appear to show dose-dependent kinetics, the Cltot were similar in spite of the difference in dosage, indicating linear kinetics. The Cltot values after oral administration were also identical with those after intravenous administration. Mean bioavailability of fosfomycin calcium salt, calculated by using equation 3, was 0.28 at both the high and the low dose. sorption and elimination. The fact that the mean value of Vd was greater than that of Vdss may also be due to the phenomenon mentioned above. Therefore, the pharnacokinetic model used in the oral study might be too simple for analyzing the Ct after oral administration.
There are three components of the temporal blood concentration profile that may influence the effectiveness of the antibiotic dosage regi-V men (7, 11, 13) : (i) the magnitude of peak blood level compared with the minimal inhibitory con=~centration (MIC); (ii) the duration of the blood =..°level above the MIC during each dosage interval;
. 3 o and (iii) the product of (i) and (ii) (the intensity factor = CdX/MIC x hours supra-MIC/dosing interval). (10) . Secondly, to achieve a supra-MIC duration for one-half or more of the dosage interval, this antibiotic should be administered at 8-to 12-h intervals. Provided fosfomycin is administered intravenously according to such a schedule, an intensity factor value of 4, which is considered a high value, could be accomplished.
It is difficult to attain a high value of C,./ MIC by the oral route, because of poor absorption (2, 10) . However, fosfomycin is largely excreted by glomerular filtration without biotransformation (9) . Accordingly, urinary levels exceed 100 ,ig/ml during 24 h with oral doses of 20 or 40 mg/kg once a day, doses adequate to inhibit a wide range of bacteria (4) .
